Seoul
South Korea
3
2025-10-02
2
2019-12-10
These are the the leading inventors for applications assigned to PHAROSGEN:
PHAROSGEN based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
NOVEL USE OF ANTICANCER AGENT PRODRUG CONJUGATE
#2 | 2017-09-14 ✅ Patent 10,501,549 granted on 2019-12-10Methods of inhibiting pathological angiogenesis with doppel-targeting molecules
#3 | 2017-06-29 ✅ Patent 10,202,459 granted on 2019-02-12Methods of inhibiting pathological angiogenesis with doppel-targeting molecules
Also check out PHAROSGEN's (Seoul, South Korea) applicant profile with 3 patent applications submitted.
126577 ⎘